for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Bosnalijek d.d. Sarajevo

BSNL.SJ

Latest Trade

15.85BAM

Change

0.00(0.00%)

Volume

400

Today's Range

15.85

 - 

15.85

52 Week Range

14.04

 - 

19.20

As of on the Sarajevo Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
15.85
Open
15.85
Volume
400
3M AVG Volume
0.00
Today's High
15.85
Today's Low
15.85
52 Week High
19.20
52 Week Low
14.04
Shares Out (MIL)
9.04
Market Cap (MIL)
136.25
Forward P/E
--
Dividend (Yield %)
3.72

Latest Developments

More

Bosnalijek dd Sarajevo Pays Dividend for FY 2012

Bosnalijek dd Sarajevo Appoints New Auditor for FY 2012

Bosnalijek dd Sarajevo Appoints New CEO and Auditor for FY 2012

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Bosnalijek d.d. Sarajevo

Bosnalijek dd Sarajevo is a Bosnia and Herzegovina-based company principally engaged in the pharmaceutical and chemical industry. The Company is an international manufacturer of drugs, disinfecting agents and food supplements for prevention, diagnostics and therapy, to maintain public health and to improve quality of life. Its pharmaceutical program includes numerous products based on different generic names for peroral, parenteral, and topical administration with effect on intestinal system and metabolism, cardiovascular system, systemic infections, skin, skeletomuscular system, nervous and respiratory system, as well as systemic hormone drugs with the exception of sex hormones. Bosnalijek dd Sarajevo operates its own development center, which comprises a number of laboratories and a library.

Industry

Biotechnology & Drugs

Contact Info

Jukiceva 53

71000

Bosnia and Herzegovina

+387.33.254400

http://www.bosnalijek.ba

Executive Leadership

Edin Dizdar

Chairman of the Supervisory Board

Nedim Uzunovic

Chief Executive Officer, Member of the Management Board

Adnan Hadzic

Acting Executive Director for Finance, Member of the Management Board

Mirela Spahic

Acting Executive Director for Operations, Member of the Management Board

Razija Peco

Acting Executive Director for Administration, Member of the Management Board

Key Stats

Price To Earnings (TTM)
15.06
Price To Sales (TTM)
1.00
Price To Book (MRQ)
0.75
Price To Cash Flow (TTM)
6.28
Total Debt To Equity (MRQ)
48.93
LT Debt To Equity (MRQ)
12.38
Return on Investment (TTM)
3.61
Return on Equity (TTM)
2.66

Latest News

Latest News

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up